The weekly litigation news digest is live. Subscribe now

IP Verse

Cytokine Derived Treatment With Reduced Vascular Leak Syndrome - EP2986312

The patent EP2986312 was granted to Cytune Pharma on Dec 15, 2021. The application was originally filed on Apr 22, 2014 under application number EP14723324A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2986312

CYTUNE PHARMA
Application Number
EP14723324A
Filing Date
Apr 22, 2014
Status
Granted And Under Opposition
Nov 12, 2021
Publication Date
Dec 15, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SANOFISep 14, 2022ZWICKERADMISSIBLE
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBSep 14, 2022WICHMANNADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP2511294
INTERNATIONAL-SEARCH-REPORTUS2009238791
INTERNATIONAL-SEARCH-REPORTWO2012175222
OPPOSITIONEP2511294
OPPOSITIONUS2012177595
OPPOSITIONWO2007001677
OPPOSITIONWO2009002562
OPPOSITIONWO2012175222
OPPOSITIONWO2014170032

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents